Paper378241
The role of glucagon in the regulation of plasma lipids.
Schade DS and 2 others. Metabolism, 1979. Cited by 57 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. The role of glucagon in the regulation of plasma lipids. Papers, record 378241. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/378241
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Glucagon | Major topic |
| Lipids | Major topic |
| Animals | |
| Diabetes Mellitus | |
| Fatty Acids, Nonesterified | |
| Heparin | |
| Humans | |
| Insulin | |
| Insulin Secretion | |
| Ketone Bodies | |
| Lipid Mobilization | |
| Liver | |
| Triglycerides |
Source PubMed
Cited by16
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 57 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,754,546 | Effect of GLP-1 receptor agonist on nutrient intake: A narrative review. | Nutr Clin Pract | 2026 | https://conductscience.org/library/papers/42754546 | PubMed |
| 41,145,428 | Non-carbohydrate anaplerotic therapy counters empagliflozin-induced diabetic ketosis. | Nutr Diabetes | 2025 | https://conductscience.org/library/papers/41145428 | PubMed |
| 41,113,119 | Safety and efficacy of 24 weeks of pemvidutide in metabolic dysfunction-associated steatotic liver disease: A randomized, controlled clinical trial. | JHEP Rep | 2025 | https://conductscience.org/library/papers/41113119 | PubMed |
| 39,735,270 | GLP-1, GIP/GLP-1, and GCGR/GLP-1 receptor agonists: Novel therapeutic agents for metabolic dysfunction-associated steatohepatitis. | World J Gastroenterol | 2024 | https://conductscience.org/library/papers/39735270 | PubMed |
| 38,675,462 | Effects of Ganjianglingzhu Decoction on Lean Non-Alcoholic Fatty Liver Disease in Mice Based on Untargeted Metabolomics. | Pharmaceuticals (Basel) | 2024 | https://conductscience.org/library/papers/38675462 | PubMed |
| 33,958,639 | Histological and transcriptomic analysis of adipose and muscle of dairy calves supplemented with 5-hydroxytryptophan. | Sci Rep | 2021 | https://conductscience.org/library/papers/33958639 | PubMed |
| 33,107,824 | Drosophila PDGF/VEGF signaling from muscles to hepatocyte-like cells protects against obesity. | Elife | 2020 | https://conductscience.org/library/papers/33107824 | PubMed |
| 31,379,062 | Regulation of insulin and adipokinetic hormone/glucagon production in flies. | Wiley Interdiscip Rev Dev Biol | 2020 | https://conductscience.org/library/papers/31379062 | PubMed |
| 30,466,162 | Cracking the combination: Gut hormones for the treatment of obesity and diabetes. | J Neuroendocrinol | 2019 | https://conductscience.org/library/papers/30466162 | PubMed |
| 29,412,829 | Problem or solution: The strange story of glucagon. | Peptides | 2018 | https://conductscience.org/library/papers/29412829 | PubMed |
| 28,846,447 | Stability of Commercially Available Glucagon Formulation for Dual-Hormone Artificial Pancreas Clinical Use. | Diabetes Technol Ther | 2017 | https://conductscience.org/library/papers/28846447 | PubMed |
| 17,584,842 | Afferent signalling through the common hepatic branch of the vagus inhibits voluntary lard intake and modifies plasma metabolite levels in rats. | J Physiol | 2007 | https://conductscience.org/library/papers/17584842 | PubMed |
| 7,153,934 | Effects of some drugs and peptide hormones on the responsiveness of the rabbit isolated gall-bladder to cholecystokinin. | J Physiol | 1982 | https://conductscience.org/library/papers/7153934 | PubMed |
| 6,809,946 | Hormonal effects on fatty acid binding and physical properties of rat liver plasma membranes. | J Membr Biol | 1982 | https://conductscience.org/library/papers/6809946 | PubMed |
| 6,131,671 | Inhibition of acetyl-CoA carboxylase activity in isolated rat adipocytes incubated with glucagon. Interactions with the effects of insulin, adrenaline and adenosine deaminase. | Biochem J | 1982 | https://conductscience.org/library/papers/6131671 | PubMed |
| 2,557,835 | Induction of ketogenesis and fatty acid oxidation by glucagon and cyclic AMP in cultured hepatocytes from rabbit fetuses. Evidence for a decreased sensitivity of carnitine palmitoyltransferase I to malonyl-CoA inhibition after glucagon or cyclic AMP treatment. | Biochem J | 1989 | https://conductscience.org/library/papers/2557835 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/378241
GET https://conductscience.org/api/papers/v1/378241/authors